ZC-B
![]() | |
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C11H14BrNO2 |
Molar mass | 272.142 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
ZC-B (3-(4-bromo-2,5-dimethoxyphenyl)azetidine) is a phenethylamine derivative which acts as a serotonin receptor agonist selective for the 5-HT2 subtypes, with an EC50 of 1.6nM at 5-HT2A, vs 5.8nM at 5-HT2C. It is related to psychedelic phenethylamine derivatives such as 2C-B and mescaline but with the ethylamine side chain replaced by an azetidine ring.[1]
See also
- DOB
- β-Methyl-2C-B
- 4C-B
- TCB-2
- LSZ
References
- ↑ US 2021/0137908, Kristensen JL, Jensen AA, Märcher-Rørsted E, "5-HT2A Agonists for Use in Treatment of Depression.", published 13 May 2021, assigned to Lophora ApS.
This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.